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Abstract: In recent years, forensic mRNA profiling has increasingly been used to identify the origin of
human body fluids. By now, several laboratories have implemented mRNA profiling and also use it in
criminal casework. In 2018 the FoRNAP (Forensic RNA Profiling) group was established among a number
of these laboratories with the aim of sharing experiences, discussing optimization potential, identifying
challenges and suggesting solutions with regards to mRNA profiling and casework. To compare mRNA
profiling methods and results a collaborative exercise was organized within the FoRNAP group. Seven
laboratories from four countries received 16 stains, comprising six pure body fluid / tissue stains and ten
mock casework samples. The laboratories were asked to analyze the provided stains with their in-house
method (PCR/CE or MPS) and markers of choice. Five laboratories used a DNA/RNA co-extraction
strategy. Overall, up to 11 mRNA markers per body fluid were analyzed. We found that mRNA profiling
using different extraction and analysis methods as well as different multiplexes can be applied to casework-
like samples. In general, high input samples were typed with high accuracy by all laboratories, regardless
of the method used. Irrespective of the analysis strategy, samples of low input or mixed stains were more
challenging to analyze and interpret since, alike to DNA profiling, a higher number of markers dropped
out and/or additional unexpected markers not consistent with the cell type in question were detected.
It could be shown that a plethora of different but valid analysis and interpretation strategies exist and
are successfully applied in the Forensic Genetics community. Nevertheless, efforts aiming at optimizing
and harmonizing interpretation approaches in order to achieve a higher consistency between laboratories
might be desirable in the future. The simultaneous extraction of DNA alongside RNA showed to be an
effective approach to identify not only the body fluid present but also to identify the donor(s) of the
stain. This allows investigators to gain valuable information about the origin of crime scene samples and
the course of events in a crime case.
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Body fluid identification 
Gene expression 
A B S T R A C T   
In recent years, forensic mRNA profiling has increasingly been used to identify the origin of human body fluids. 
By now, several laboratories have implemented mRNA profiling and also use it in criminal casework. In 2018 the 
FoRNAP (Forensic RNA Profiling) group was established among a number of these laboratories with the aim of 
sharing experiences, discussing optimization potential, identifying challenges and suggesting solutions with 
regards to mRNA profiling and casework. To compare mRNA profiling methods and results a collaborative ex-
ercise was organized within the FoRNAP group. Seven laboratories from four countries received 16 stains, 
comprising six pure body fluid / tissue stains and ten mock casework samples. The laboratories were asked to 
analyze the provided stains with their in-house method (PCR/CE or MPS) and markers of choice. Five labora-
tories used a DNA/RNA co-extraction strategy. Overall, up to 11 mRNA markers per body fluid were analyzed. 
We found that mRNA profiling using different extraction and analysis methods as well as different multiplexes 
can be applied to casework-like samples. In general, high input samples were typed with high accuracy by all 
laboratories, regardless of the method used. Irrespective of the analysis strategy, samples of low input or mixed 
stains were more challenging to analyze and interpret since, alike to DNA profiling, a higher number of markers 
dropped out and/or additional unexpected markers not consistent with the cell type in question were detected. It 
could be shown that a plethora of different but valid analysis and interpretation strategies exist and are suc-
cessfully applied in the Forensic Genetics community. Nevertheless, efforts aiming at optimizing and harmo-
nizing interpretation approaches in order to achieve a higher consistency between laboratories might be 
desirable in the future. The simultaneous extraction of DNA alongside RNA showed to be an effective approach to 
identify not only the body fluid present but also to identify the donor(s) of the stain. This allows investigators to 
gain valuable information about the origin of crime scene samples and the course of events in a crime case.   
1. Introduction 
The identification of human body fluids in biological trace material 
can crucially contribute to the stains’ contextualization and thus provide 
essential information for the investigation and the prosecution of 
criminal offences [1]. Therefore, analysis of biological evidence 
typically begins with a screening for the presence of body fluids. In the 
last decades new techniques for the identification of body fluids have 
been developed, including forensic RNA analysis [2–11], tissue specific 
methylation [12–16], microbial forensics [17–21] and proteomics [22, 
23]. Since each body fluid or tissue type is associated with cells exhib-
iting a typical transcriptome for that cell type, the detection of specific 
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RNA transcripts can be used to identify the presence of a body fluid or 
tissue type. 
In recent years, several mRNA markers have been identified for the 
forensically most relevant body fluids / tissue types encountered in 
criminal casework (blood, menstrual blood, nasal and vaginal secretion, 
saliva, semen, skin) [24–36]. The classical workflow of mRNA profiling 
includes RNA extraction, DNase treatment, reverse transcription, 
marker-specific endpoint PCR and capillary electrophoresis (CE) or 
detection by qPCR [4]. To reduce sample consumption and time, RNA 
can be co-extracted along with DNA from the same sample. This 
approach enables the simultaneous identification of the body fluid 
donor by STR profiling and the identification of the tissue / fluid source 
of origin by mRNA profiling [37,38]. Although RNA degrades more 
quickly in post-mortem tissues and ex-vivo than DNA (e.g. due to the 
chemical structure, RNases present in the environment, humidity and 
UV-radiation), mRNA has been demonstrated to be more stable than 
formerly supposed depending on the storage conditions [32,35,39]. In a 
series of collaborative exercises, the European DNA Profiling Group 
(EDNAP) evaluated the performance, robustness and reproducibility of 
different mRNA markers for the identification of blood, saliva, semen, 
vaginal secretion, menstrual blood and skin [40–44]. For many labora-
tories this was a good opportunity to get acquainted with the method 
and gain experience. Furthermore, the European Forensic Genetics 
Network of Excellence (EUROFORGEN-NoE) examined the interpreta-
tion of RNA profiling data [45]. In the meantime, mRNA profiling has 
been implemented and accredited according to ISO 17025 in several 
laboratories, is regularly used in casework and accepted by courts. 
Expression of body fluid- or cell-type specific transcripts is typically 
abundant in the respective body fluid / tissue, but not necessarily absent 
in others. Many forensic mRNA markers are also detected at low fre-
quencies in non-target body fluids. Roeder et al. [34] developed a 
scoring system which minimizes the chances of misidentification of a 
sample due to marker expression in a non-target body fluid. Each marker 
is weighed according to its specificity for a certain body fluid. For a 
specific sample the body fluid specific values of the detected mRNA 
markers are summed up to produce a body fluid score. Threshold scores 
are then determined for the identification of each body fluid. Linden-
bergh et al. [46] proposed a scoring method based on replicate analyses, 
which allows an unbiased interpretation of mRNA results in casework. 
The replicates are used to determine how often a signal is present 
(observed number of markers) relative to the times a signal could have 
occurred (maximum number of markers, which could have been 
detected per body fluid). Depending on the result of this ratio, a body 
fluid is reported as “observed”, “not observed” or “sporadically 
observed”. De Zoete et al. [47] proposed a probabilistic approach to 
identify body fluids using naive Bayes and multinomial logistic regres-
sion. Dørum et al. [48] built a probabilistic model, which incorporates 
quantitative information (MPS read counts) instead of only the pre-
sence/absence of markers. Recently, Iacob et al. [49] introduced a ma-
chine learning prediction model that incorporates probabilistic 
information based on MPS data. 
In the last decade, massively parallel sequencing (MPS) technologies 
have constantly evolved, leading to a decrease in operational costs and 
an increase in throughput [50]. By now, several MPS kits for forensic 
applications (autosomal STRs, Y- and X-STRs, identity, phenotypic and 
ancestry SNPs, as well as whole mtDNA) and different platforms are 
commercially available and are used for casework [51]. Besides, DNA 
sequencing and targeted RNA sequencing has been introduced in 
forensic stain analysis. Hanson et al. [52] developed an MPS assay for 
the identification of body fluids using 33 tissue-specific mRNA markers 
on the Illumina MiSeq platform. The assay was then tested within the 
EUROFORGEN-NoE and EDNAP groups [53]. The results of this 
collaborative mRNA MPS exercise suggest that mRNA sequencing is a 
reliable body fluid identification method, which could be added to the 
repertoire of forensic MPS panels. 
In 2018 the FoRNAP group was established as a community of 
laboratories using mRNA profiling in casework with the aim of sharing 
experiences, discussing optimization potential and suggesting solutions 
with regards to casework. A collaborative exercise among the FoRNAP 
laboratories was organized by the Zurich Institute of Forensic Medicine, 
Switzerland. The aim was to compare mRNA profiling methods and 
results by analyzing a set of mock casework samples. The laboratories 
were asked to analyze the provided stains with their own methods (PCR/ 
CE or MPS) and markers. Here we present the results of the seven 
participating laboratories. 
2. Material and methods 
2.1. Participants and samples 
Seven laboratories from Germany, the Netherlands, Slovenia and 
Switzerland participated in this collaborative exercise. All participants 
are accredited according to ISO 17025 and actively employ forensic RNA 
analysis in casework. 
The organizing laboratory (Zurich Institute of Forensic Medicine, 
Switzerland) prepared 16 stains, comprising six pure body fluid / tissue 
stains and mock casework samples (Table 1). Body fluids / tissues were 
collected from healthy volunteers with their informed consent. The 
sampling was approved by the local ethics commission KEK (declaration 
of no objection No. 24-2015). Thirteen single source and three mixed 
stains were prepared as depicted in Table 1. After preparation, all 
samples were dried at room temperature for at least 12 h. The compo-
sition of the stains was not disclosed to the participants. At the orga-
nizing laboratory, sample preparation and experimental part were done 
by different persons; the experimenter had no knowledge of the stain 
composition. The samples were not tested by the organizing laboratory 
prior to shipment and were sent at ambient temperature by courier to 
the different laboratories. All parcels were received within two days. 
Participants were asked to store the samples at room temperature in the 
dark until further processing. 
2.2. RNA and DNA analyses 
The participating laboratories were asked to analyze the provided 
stains using their standard mRNA profiling protocol, as well as the 
interpretation and reporting guidelines, they are using in casework. Four 
laboratories (Labs 1, 3, 4, 7) used an RNA/DNA co-extraction approach, 
while two laboratories (Labs 2 and 5) extracted RNA only. Lab 6 used a 
co-extraction as well as an RNA only extraction approach, and we will 
refer to their results as Lab 6a and Lab 6b, respectively. A summary of 
the different RNA and DNA analysis methods used is displayed in Ta-
bles 2 and 3. An overview of the markers used for mRNA profiling is 
shown in Table 4. 
Most laboratories analyzed mRNA markers for the identification of 
blood, saliva, semen, vaginal secretion, menstrual blood and skin. Lab 4 
only used markers for saliva, menstrual blood and vaginal secretion and 
Lab 7 did not use markers for skin. In addition, some laboratories used 
markers for housekeeping genes (Labs 1, 3, 5 and 7), gender (Labs 2, 3, 5 
and 7) and nasal secretion (Labs 3 and 7). Six laboratories employed a 
PCR/CE based method (Labs 1, 3, 4, 5, 6a and 7), while laboratories 2 
and 6b analyzed the stains using an MPS approach on the Illumina 
MiSeq/FGx platform. The PCR/CE based laboratories used different 
RNA amplification strategies. Three laboratories performed replicate 
analyses (Labs 1, 6a and 7). Laboratory 1 performed duplicate RT ana-
lyses and PCR replicates with alternative input volumes when deemed 
necessary. Laboratory 6a used different body fluid / tissue specific 
primer multiplexes to confirm the results of the initial screening multi-
plex. Laboratory 7 amplified each cDNA four times. The remaining five 
participants performed single analyses. 
Different strategies were employed by the laboratories to analyze the 
DNA (Table 3). Two laboratories repeated the PCR if deemed necessary 
based on the quality of the profiles (Labs 6a and 7), while three 
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laboratories did not perform replicate analyses (Labs 1, 3 and 4). In 
addition, laboratory 4 generated Y-STR profiles (Yfiler™ Plus Kit, 
Thermo Fisher Scientific) for the stains. The profiles were searched in 
the YHRD database, using the ancestry information function on the 
YHRD website (https://yhrd.org) [54]. In the end the participating 
laboratories were asked to fill in a questionnaire describing what 
methods they used, the quantification results (RNA and optionally 
DNA), the mRNA profiling and optionally STR analysis results and a 
tentative interpretation. 
2.3. Compilation of RNA and DNA results 
The composition of the stains was not disclosed to the participants 
during the runtime of the exercise. The compilation of the results was 
performed at the Zurich Institute of Forensic Medicine. Based on the 
body fluid / tissue input amount and the RNA/DNA quantification re-
sults, stains were classified into high input stains (No. 1, 4, 8, 9, 10.1, 
10.2, 12, 15), low input stains (No. 2, 3, 5, 6, 13, 16) and mixed stains 
(No. 7, 11, 14). 
Within the RNA results, markers were categorized into 1) correctly 
identified, 2) missing and 3) additional markers (not expected in the 
stain). Graphs showing the percentage of the average peak height / read 
count were generated per stain. In addition, results were analyzed per 
laboratory and per method (CE/MPS) as well as per marker. The labo-
ratories applied their own thresholds to call a marker (Table 2). Markers 
not meeting this specified threshold were omitted from the analysis. For 
menstrual blood samples (stains 4 and 9), blood, vaginal secretion, and 
menstrual blood markers were regarded as possible markers. Menstrual 
blood had to be reported to be present in order for the result to be 
correct. For nose bleed (stain 2), blood markers and nasal secretion 
markers (if used by the analyzing laboratory) were taken into account. 
For the azoospermic semen sample (stain 16), only markers for seminal 
fluid were considered as correct markers. 
Within the DNA results, a locus was marked as correct, when all 
required alleles were present (see Table 3 for thresholds). Results were 
depicted as ratios, based on the number of correctly typed and missing 
loci. 
3. Results 
3.1. RNA and DNA extraction 
The phenol/chloroform based RNA extraction method used by 
Laboratory 6b produced the highest RNA yields in all but two stains, 
when considering the six laboratories that quantified the RNA (Fig. 1). 
Samples containing vaginal secretion or menstrual blood showed the 
highest RNA concentrations, while the fingerprint on the glass slide and 
1 μL of blood on a piece of cord provided the lowest RNA concentrations 
(Fig. 1). 
Of the five laboratories that analyzed the DNA, the DNA/RNA co- 
extraction strategy using the QIAamp DNA mini kit (Qiagen) in combi-
nation with the mirVana miRNA isolation kit (Thermo Fisher Scientific) 
resulted in the highest DNA concentrations (Labs 1, 3, 7). Overall, stains 
containing menstrual blood, vaginal secretion or semen (with the 
exception of the azoospermic semen stain 16) showed the highest DNA 
yields (Fig. 1). The DNA concentrations were lowest in skin samples 
(finger print, skin collected by rubbing lower arm), 1 μL of blood on 
piece of cord and 5 μL azoospermic semen on cotton swab. 
3.2. mRNA profiling 
The numbers of correctly typed, missing and additional markers per 
laboratory and per stain are displayed in Fig. 2. Overall, high input 
samples (No. 1, 4, 8, 9, 10.1, 10.2, 12, 15) showed higher numbers of 
correctly identified markers as well as lower numbers of missing 
markers compared to the low input samples (No. 2, 3, 5, 6, 13, 16) and 
mixed samples (No. 7, 11, 14). 
Fig. 3a and 3b give an overview of specific and unspecific markers 
observed in each stain and for each laboratory. Since the laboratories 
analyzed different markers, the figures display marker category rather 
than the individual markers. The bars show the sum of peak heights / 
read counts for all markers specific to a body fluid category, relative to 
the total sum of peak heights / read counts for the sample. Housekeeping 
/ reference gene markers were not included in the calculation of the total 
peak height / read counts per sample. For the laboratories with repli-
cates, the average percentage is shown with standard errors indicated on 
the bars. Note that STATH is included in the saliva marker category only, 
although two laboratories reported it as a combined nasal and saliva 
marker. In most of the high input stains (Fig. 3a) the body fluid specific 
markers were identified correctly. The exceptions are stain 15 in which 
the blood markers were not detected by Lab 6a, and stain 9 where Lab 1 
and Lab 6b did not detect the menstrual blood markers. In the low input 
and mixture stains (Fig. 3b) all laboratories detected the blood markers 
in stain 2 (nose blood), while in stain 13 only four laboratories found 
blood. Semen markers were detected in all stains where semen was 
present, with one exception. In the pure skin sample (stain 6), four out of 
Table 1 
Overview of the 16 stains prepared by the organizing laboratory.   
Body fluid(s) Age of body fluid Substrate Sample processing Classification 
1 25 μL saliva fresh swab whole swab/piece pure / high input 
2 nose bleed blood 2 years tissue (0.5 × 0.5 cm) whole swab/piece low input 
3 saliva fresh tea spoon swab the mouth part of the spoon and use 
whole swab for extraction 
low input 
4 menstrual blood 1 year 1/4 swab whole swab/piece pure / high input 
5 finger print fresh microscope slide (finger unwashed) swab the upper side (“Superfrost” and “5” 
visible) of glass surface 
low input 
6 skin collected from forearm fresh swab (forearm unwashed) whole swab/piece pure / low input 
7 5 μL blood +
5 μL semen 
1 year (blood), 
3.5 years (semen) 
swab whole swab/piece mixed 
8 vaginal secretion fresh 1/4 swab whole swab/piece pure / high input 
9 menstrual blood fresh cotton panty (ca. 0.5 × 0.5 cm) whole swab/piece high input 
10 vaginal secretion +
10 μL semen 
fresh (vaginal secretion),  
4 years (semen) 
Finger of latex glove (vaginal  
secretion on outside, semen on inside) 
swab, extract and analyze outer and inner parts 
separately 
high input 
11 saliva (child) on  
forearm (mother) 
fresh swab (forearm unwashed) whole swab/piece mixed 
12 25 μL semen 3.5 years swab whole swab/piece pure / high input 
13 1 μL blood 1 year cord (unwashed) whole swab/piece low input 
14 vaginal secretion +
5 μL semen 
fresh (vaginal secretion), 
5 years (semen) 
1/4 swab whole swab/piece mixed 
15 25 μL blood 1 year swab whole swab/piece pure / high input 
16 5 μL semen (azoospermic) 2 years cellulose cut out area where stain is suspected to be low input  
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six laboratories detected skin markers, while five laboratories detected 
skin in the saliva-skin mixture (stain 11). The saliva markers had few 
unspecific reads, however Labs 2 and 7 did not detect saliva in stain 3, 
and Lab 3 did not detect saliva in stain 11. Some variation can be seen 
for the laboratories with replicates. 
3.3. Observation of additional mRNA markers 
An overview of the detected additional markers per laboratory and 
per stain is depicted in Figs. 2, 3a, 3b and Table 5. High input samples 
(No. 1, 4, 8, 9, 10.1, 10.2, 12, 15) show a higher number of additional 
markers than low input samples (No. 2, 3, 5, 6, 13, 16). Mixed samples 
Table 2 
Overview of the RNA analysis and interpretation methods used by the different laboratories. *Laboratories 3 and 4 did not quantify the RNA extract +according to MPS 
protocol.   
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(No. 7, 11, 14) show several additional markers across all participating 
laboratories. Skin markers were the most frequently observed additional 
markers. These markers were identified in 11 out of 16 samples, 
although the samples did not purposefully comprise skin. Blood and 
vaginal secretion markers were also detected unexpectedly in some 
samples. Laboratories reporting replicate results (Labs 1, 6a and 7) 
tended to show a higher number of additional markers compared to the 
remaining participants, because with each replicate performed chances 
of detecting additional markers increased. Thus it depends on the 
interpretation guidelines how these observations are assessed. 
3.4. Assessment of the body fluid / tissue specific mRNA markers 
Three to six mRNA markers per body fluid / tissue have been 
analyzed by three or more laboratories and are displayed in Supple-
mentary Fig. 1. Most blood markers were very specific (they did not 
appear in non-target body fluids), but not very sensitive (they were not 
detected). Saliva, semen, vaginal secretion and menstrual blood markers 
were detected at very high numbers, with only a few missing markers in 
the respective stains. The skin markers LCE1C and CDSN were readily 
detected, but they also showed up in other body fluids. 
3.5. STR profiling 
Five laboratories used a DNA/RNA co-extraction approach and 
generated DNA profiles in addition to mRNA profiling. The compilation 
of the DNA results showed that the high input stains (No. 1, 4, 8, 9, 10.1, 
10.2, 12, 15) were typed without mistakes; only in two stains a single 
dropout was observed (Table 6). Even within the low input samples (No. 
2, 3, 5, 6, 13, 16) full DNA profiles were obtained for most stains. The 
skin samples, stain 5 (finger print on glass slide) and stain 6 (skin 
collected by swabbing forearm), were most challenging. Stain 5 was 
typed with >75 % of correctly typed loci by only two laboratories, while 
for stain 6 four laboratories reported >75 % of correctly typed loci. 
Some laboratories reported up to eight different alleles per locus in 
stains 5 and 6 (data not shown). Within the mixed stains (No. 7, 11, 14) 
almost full DNA profiles were generated for stains 7 and 14 (including all 
alleles of the two contributors). Stain 11 (saliva on skin) was chal-
lenging, only one laboratory reported >75 % of correctly typed loci, 
while four laboratories typed <50 % of the loci. Poor STR profiling re-
sults were in line with low DNA concentrations. The lowest DNA con-
centrations were obtained for stains 5, 6 and 11 (Fig. 1). 
Table 3 
Overview of the DNA analysis and interpretation methods used by the different laboratories to generate STR profiles. *no DNA extraction was performed 
+Quantification method according to Lindenbergh et al [55].   
Lab 1 Lab 
2 
Lab 3 Lab 4 Lab 
5 





Qiagen QIAamp DNA 
mini kit, Ambion 
mirVana miRNA 
isolation kit 
* Qiagen QIAamp 
DNA mini kit, 
Ambion mirVana 
miRNA isolation kit 
Qiagen EZ1 
Advanced XL 
* Qiagen AllPrep RNA/DNA 
Co-Extraction kit 
* Qiagen QIAamp DNA 







* Alu-repeat based 
quant +
Thermo Fisher 
Quantifiler Trio DNA 
Quantification Kit 
* Promega Quantifluor ONE 
dsDNA 




STR kit Promega PPL ESX 17 
fast 




Fisher Y-filer plus 
* Thermo Fisher NGM Select * Thermo Fisher NGM 
Select and NGM Detect 
DNA input into 
PCR 
0.5 ng/μl in 25 μL 
reaction volume 
* aiming at 500 pg 1−10 μl * 1−10 μl * 350−400 pg 
Genetic 
Analyzer 
3500 * 3130xl 3500 * 3130xl * 3130 
Threshold to 
call a peak 
50 rfu * 50 rfu 100 rfu * 50 rfu * 50 rfu 
Replicate 
analyses 
DNA-input into PCR 
based on quantification 
results. No replicate 
amplifications. 
* no no * DNA-input into PCR based on 
quantification results. If 
neccessary PCR was repeated 
with adjusted input volume. 
* Replicates if necessary 




Allele is present, when 
the threshold of 50 rfu is 
reached. 
* Allele is present, 
when the threshold 
of 50 rfu is reached. 
Allele is present, 
when the threshold of 
100 rfu is reached. 
* Allele is present, when the 
threshold of 50 rfu is 
reached. 
* Allele is present, when 
the threshold of 50 rfu 
is reached.  
Table 4 
Summary of mRNA markers used by the different laboratories. Brackets behind the markers indicate by how many laboratories the marker was used. +STATH is used to 
detect saliva and nasal secretion, *marker used to detect male gender, **marker used to detect female gender.  
Blood Semen Saliva Nasal Vaginal Menstrual Skin Ref. Gene Gender 
ALAS2 (7) KLK3 (7) HTN1 (3) BPIFA1 (2) CYP2A6 (2) LEFTY2 (1) CCL27 (3) ACTB (4) RPS4Y1* (4) 
AMICA1 (1) PRM1 (6) HTN3 (7) STATH+ (2) CYP2B7P1 (8) MMP10 (6) CDSN (3) 18S-rRNA (4) XIST**(3) 
ANK1 (3) PRM2 (3) MUC7 (1)  DKK4 (2) MMP11 (7) COL17A1 (2)  
CD3G (3) SEMG1 (6) PRB3 (2)  FAM83D (2) MMP7 (8) IL1F7 (1)   
CD93 (3) SEMG2 (1) PRB4 (2)  HBD1 (1) MMP3 (1) IL37 (2)   
HBA (1) TGM4 (3) PRH2 (2)  MUC4 (6) SFRP4 (1) KRT77 (2)   
HBB (5)  STATH+ (8) MYOZ1 (5) STC1 (2) LCE1C (4)   
PBGD (1)    Lcris (2)  LCE1D (1)   
SPTB (3)    Lgas (2)  LCE2D (1)       
Ljen (2)  LOR (1)         
SERPINA12 (2)   
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3.6. Interpretation 
Participating laboratories were asked to fill in a questionnaire where 
information about the interpretation of the stains (body fluid(s) / tissue 
of origin, number of contributors and gender) was collected. The 
interpretation was done using the laboratories’ standard interpretation 
rules and/or guidelines, based on all obtained results. Results are 
depicted in Table 7 for mRNA and Table 8  for STR profiling. In the high 
input category (stains 1, 4, 8, 9, 10.1, 10.2, 12, 15) most body fluids 
were identified correctly by mRNA profiling and the number and gender 
of the contributors was retrieved from DNA and/or RNA profiling. Only 
two mRNA results were incorrect or showed no result and two gender 
assignments were incorrect. For the identification of body fluids the 
main issue for a correct interpretation was the detection of additional 
mRNA markers. 
The low input stains (No. 2, 3, 5, 6, 13, 16) were more difficult to 
infer. Stains 2 and 16 were interpreted correctly by all laboratories. Two 
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Fig. 1. RNA and DNA concentrations (log 10 (ng/μl)) shown per stain. Six laboratories quantified RNA, while five laboratories quantified DNA. Each symbol 
corresponds to one measurement, and each laboratory is identified by a different shaped/colored icon. Stains 1, 4, 8, 9, 10.1, 10.2, 12, 15 are high input samples, 
stains 2, 3, 5, 6, 13, 16 are low input samples, stains 7, 11, 14 are mixtures. 
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bleed blood) did not show any nasal mucosa markers. Four laboratories 
stated correctly that sample 16 (azoospermic semen) only contains 
markers for seminal fluid and might originate from an azoospermic 
donor. Stain 3 (saliva on tea spoon), stain 5 (finger print on glass), stain 
6 (skin from forearm) and stain 13 (1 μL blood on cord) were challenging 
samples. About half of the laboratories identified the body fluids in stain 
3, 6 and 13 correctly, whereas stain 5 was correctly typed by two par-
ticipants. For stains 5 and 6 (touch samples) the number of contributors 
and gender were difficult to identify. Only one laboratory assigned the 
number of contributors and the gender of the donors of stain 6 correctly. 
In the mixed stain category (No. 7, 11, 14) at least one of the two 
body fluids was identified correctly by most laboratories. Some labo-
ratories reported additional body fluids besides the correct ones. In stain 
7 (blood + semen) semen was identified by all laboratories, but the 
blood component was identified only by two laboratories. However, all 
five laboratories that performed DNA profiling detected the two con-
tributors. Both components in mixed stain 11 (saliva + skin) were 
correctly identified by four laboratories, another three laboratories 
identified one of the two components. Based on the DNA results only two 
out of five laboratories detected the two contributors. For stain 14 
(vaginal secretion + semen) both components were identified by all 
laboratories, but four laboratories reported additional body fluids. Based 
on DNA results and/or gender markers seven out of eight laboratories 
detected the two contributors. 
One laboratory also generated Y-STR profiles for the stains and 
identified the donors to originate from Western Europe, which is correct. 
3.7. CE versus MPS 
When comparing the conventional PCR/CE method (Labs 1, 3, 4, 5, 
Fig. 2. RNA results per laboratory and per stain. The number of markers (y-axis) is displayed per stain as number of correct (blue), missing (orange) and additional 
markers (grey) on the x-axis. Two laboratories did not test for all body fluids; therefore, the respective stains were omitted from the graphs. *All three seminal fluid 
markers were detected below threshold. Nevertheless, semen was reported to be present in the sample. 
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6a, 7) and the MPS approach (Labs 2, 6b), it becomes evident that the 
number of correctly identified RNA markers tends to be lower in the 
samples analyzed by MPS (Fig. 3). Nevertheless, MPS laboratories were 
not lagging behind in correctly identifying the body fluids in the high 
input stains. One exception is stain 9 (menstrual blood), where no result 
was reported by one MPS participant. Low input samples were more 
challenging to analyze. No results or not correctly identified body fluids 
were reported from laboratories employing MPS as well as CE/PCR. 
4. Discussion 
Seven laboratories within the FoRNAP group, that are using mRNA 
profiling in casework, participated in this exercise. They analyzed a set 
of 16 mock casework samples using their standard mRNA profiling 
protocol (PCR/CE or MPS based). The aim of this study was to compare 
mRNA profiling methods including RNA/DNA co-extraction strategies 
and the resulting outcomes. To evaluate the difficulties faced when 
working with casework samples, the organizing laboratory prepared 13 
single source stains ranging from high input (e.g. 25 μL of saliva on a 
cotton swab) to low input (e.g. 1 μL of blood on a piece of cord) and three 
mixtures. 
When comparing the RNA concentrations between the participants, 
it was striking that higher RNA concentrations did not lead to better 
results. This could be explained by differences between the protocols 
used by the participating laboratories and the resulting quality of the 
RNA. In addition, residual phenol-chloroform might inhibit the down-
stream sample analysis. Another factor might be an overestimation of 
the human or non-human (bacterial) RNA content. On a side note, 
Grabmüller et al. [56] reported that comparing RNA quantification 
values obtained with different quantification methods is difficult. This is 
not relevant in our study, since all participants used fluorescence-based 
nucleic acid quantification methods (Qubit or Quantus fluorometer) for 
total RNA quantification. 
With mRNA profiling, almost all body fluids of the high input sam-
ples were correctly identified. Stains of low input and mixtures were 
more challenging to analyze and interpret. However, low input samples 
were correctly identified by more than half of the laboratories, while at 
least one of the body fluids of each sample in the mixed stain category 
was reported correctly by most participants. Other studies reported that 
in mixed body fluid samples usually one of the body fluids is dominating 
[48,53,57]. This is probably dependent both on the mixture proportions 
and the types of body fluids involved. Therefore, it has to be kept in mind 
that for mixtures containing body fluids / tissues with generally low 
RNA amounts, e.g. blood, semen and skin, this component might be 
missed due to overrepresentation of the dominant body fluid. As a 
consequence, it should be considered to include a respective caveat for 
the interpretation of casework samples to clarify that the failure to 
detect a particular body fluid does not categorically exclude the pres-
ence of this body fluid in the original sample. 
Skin samples proved most difficult to analyze, both for RNA and DNA 
profiling. Skin cells of the outermost layer of the epidermis are dead, 
keratinized and lack a nucleus. Van den Berge et al. [36] showed that for 
skin samples RNA profiling is more sensitive than DNA profiling, while 
the opposite is true for blood, menstrual blood, saliva and semen. 
Samples containing low amounts of blood (stains 7, 13, 15) were also 
difficult to analyze and interpret. Especially stain 7 (5 μL of semen mixed 
Fig. 3. a: High input stains: comparison of peak heights / read counts in each marker category (blood, saliva, semen, vaginal secretion, menstrual blood and skin) 
relative to the peak height / read count sum for the sample. Labs 1, 6a and 7 had replicates, and the error bars represent variation between replicates as ±1 standard 
error about the mean. Lab 4 only tested for saliva, vaginal secretion and menstrual blood. The unspecific peaks for vaginal secretion in stains 12/15 may appear 
disproportionately large due to the lack of body fluid specific markers. Lab 7 did not test for skin. Only labs 3 and 7 had nasal secretion markers. 
b: Low input and mixed stains: comparison of peak heights / read counts in each marker category (blood, saliva, semen, vaginal secretion, menstrual blood, skin) 
between labs. The y-axis shows the percentage of peak heights/read counts attributed to a marker type, relative to the peak height / read count sum for the stain. Labs 
1, 6a and 7 had replicates, and the error bars represent variation between replicates as ±1 standard error about the mean. Lab 4 only tested for saliva, vaginal 
secretion and menstrual blood. The unspecific peaks for vaginal secretion in stains 16/7 may appear disproportionately large due to the lack of body fluid specific 
markers. Lab 7 did not test for skin. Only labs 3 and 7 had nasal secretion markers. 
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with 5 μL of blood) and stain 13 (1 μL of blood on a piece of cord) were 
challenging. Several blood markers were not detected in these stains, 
except for the very sensitive blood marker HBB. An explanation might be 
that the blood used to prepare the stains has been stored frozen (−20 ◦C) 
for about one year in EDTA coated sampling tubes. Several studies found 
that expression levels of different mRNA species change over time when 
stored ex-vivo for more than 24 h and that storing samples at low tem-
peratures does not prevent degradation [58]. It could be shown that 
freezing whole blood samples [58] or adding EDTA dramatically reduces 
RNA quality when stored for a longer period of time [59]. The cellular 
origin of stain 9 (menstrual blood on cotton panty) was also difficult to 
determine. Two laboratories did not detect any menstrual blood 
markers, but only reported blood as present. The sample was collected 
on day 3 of the menstrual cycle. It is known that menstrual blood 
comprises several tissue types such as blood, degraded endometrial 
tissue and epithelial cells from the vaginal lumen [4,60]. The blood 
content of menstrual blood is only about 30–50 % of the total flow 
volume. A study by Hanson et al. [52] indicated that the cellular 
composition changes across the course of menses. On days 1 and 2 of the 
menstrual cycle, menstrual blood markers were detected at a very high 
level, from day 3 on, these markers then decreased, while the opposite 
trend was observed for the vaginal secretion markers. The highest 
expression of blood markers was observed on day 4 of a 6-day menstrual 
cycle. No specific nasal secretion stain was included in the exercise to 
test the nasal mucosa markers (BPIFA, STATH). Stain 2 (nose bleed 
blood on a tissue) could have shown nasal mucosa markers but did not, 
probably because it was a low input and old stain. 
When comparing the performance of MPS and CE/PCR based 
methods the number of correctly identified RNA markers tends to be 
lower in the samples analyzed by MPS. However, it has to be kept in 
Table 5 
Correctly typed and additional RNA markers per stain and laboratory. Samples are sorted into high input stains (No. 1, 4, 8, 9, 10.1, 10.2, 12, 15), low input stains (No. 
2, 3, 5, 6, 13, 16) and mixed stains (No. 7, 11, 14). Additional markers are subdivided into 1) skin markers, 2) markers which could be co-expressed in the body fluid (e. 
g. menstrual blood markers in vaginal secretion), due to sampling artefacts (e.g. blood markers in saliva or vaginal secretion samples) or can be explained by sexual 
intercourse (e.g. semen marker in vaginal secretion or menstrual blood samples) and 3) where cross-reactivity is suspected. +Lab 4 only used markers for saliva, 
menstrual blood and vaginal secretion. ++Lab 7 did not use markers for skin. +++ STATH was not used by Lab 2 as marker for nasal secretion but for saliva only. Since it 
has been described as marker for nasal secretion, it is listed in the category “co-expression possible”.  
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mind that MPS laboratories analyzed more markers per body fluid, 
probably including markers that are expressed at lower levels. Never-
theless, laboratories using MPS were not lagging behind when analyzing 
high input stains. The analysis of mixed and low input stains was chal-
lenging for all participants, irrespective of the method. The MPS pro-
tocol requires substantial amounts of RNA. The library preparation 
protocol used by Hanson et al. [52] and Ingold et al. [53] for example 
needs 50 ng of RNA for the degraded sample protocol. Depending on the 
sample type this amount is difficult to reach when working with forensic 
samples. In turn, this may lead to low read counts posing a genuine 
challenge for the interpretation of the data. This highlights the need for 
further improvement of library preparation and sequencing protocols. 
However, promising results have been obtained for body fluid identifi-
cation not only by the present study but also by others [52,53]. 
Several additional (not expected) RNA markers were detected in the 
provided stains. This could be due to real contaminations or sampling 
artefacts. E.g. in stain 10 (finger of latex glove, outside vaginal secretion 
10.1, inside semen 10.2) the detection of vaginal markers on the inside 
by two laboratories can be ascribed to sample processing. Nevertheless, 
the semen markers were detected as major component, whereas vaginal 
markers were the minor component. The detection of semen markers in 
vaginal secretion or menstrual blood samples could be due to sexual 
intercourse. In this regard, no information was collected from the body 
fluid donors. The detection of sporadic blood markers in non-blood 
samples might be due to an invasive sampling procedure, e.g. cotton 
swabs inserted into the vagina might have caused micro lesions in the 
mucosa (stains 8, 10.1). In sample 14 (vaginal secretion + semen), 
markers for menstrual blood and blood were detected in addition to the 
vaginal markers. These vaginal secretion samples were collected on day 
8 of the menstrual cycle and could explain the high detection rate of 
markers for menstrual blood and blood. In 11 out of the 16 samples, skin 
markers were detected although the samples did not comprise skin. 
Touching skin during sample collection cannot be avoided (e.g. nose 
bleed blood on a piece of tissue, blood collection by finger prick, or 
vaginal secretion and menstrual blood collection on cotton swabs) and 
this could be the reason for the wide-ranging detection of the very 
sensitive skin markers. Since skin is a ubiquitous source of cells in any 
forensic scenario, the presence of skin markers must be interpreted very 
cautiously in the context of a given case. 
Another explanation why additional RNA markers were detected, is 
that some mRNA markers might be affected by cross-reactivity. Body 
fluid- or cell-type specific mRNA markers have been selected based on 
their high expression levels in target tissues. Nevertheless, transcription 
might not be completely absent in other tissues. Therefore, background 
expression in non-target tissues remains possible. The skin markers (e.g. 
LCE1C) are very sensitive and may well be expressed in low levels in 
other body fluids. In a study by van den Berge et al. [45] cross-reactivity 
of skin markers (LOR and to lesser extent CDSN) were reported for 
vaginal mucosa samples. Saliva, vaginal secretion, menstrual blood and 
nasal secretion are derived from mucous membranes, which show a very 
similar composition; therefore such mRNA markers are prone to 
cross-reactivity. The detection of HBD1 in semen could be due to its 
expression in the germ line from pachytene spermatocytes to late sper-
matids [61]. In addition, the peptide can also be present in ejaculated 
spermatozoa and seminal plasma. MUC4 was shown to cross-react with 
semen and saliva [33]. Besides, it cannot be excluded that different 
primer designs and capillary electrophoresis instruments used by the 
participants may have led to differences in assay specificity and sensi-
tivity. This might have had an influence on the detection of additional 
markers. 
In general, the detection of additional markers poses a challenge 
when it comes to the interpretation of the results as body fluids or tissues 
not being present might be reported as observed. A good strategy to cope 
with variable expression and cross-reactivity is the use of interpretation 
and reporting guidelines. We mentioned the scoring systems [34,46] and 
probabilistic approaches [47,48] to minimize the chances of misidenti-
fication of a sample due to marker expression in a non-target body fluid. 
Nevertheless, there is still an ongoing discussion how to interpret mRNA 
data and present the evidence in court. In this study, one laboratory 
applied the scoring method based on 4 replicate analyses [46]. Another 
participant applied a different replicate strategy by analyzing the stains 
first with a screening multiplex containing primers for all body fluids, 
followed by body fluid specific multiplexes to confirm the results, but 
did not use an interpretation tool. A third laboratory performed RT and 
PCR replicate analyses. The other laboratories did not perform replicates 
or use an interpretation tool. This plethora of analyses and 
Table 6 
Number of correctly typed STR loci. For single source stains, loci were marked as correct when the correct alleles were present (irrespective of additional alleles). For 
the mixed stains, loci were marked as correct, when all alleles of both contributors were present. Dark and light green boxes represent 100 % and >75 % correctly 
identified loci, respectively. Orange and red boxes represent 50 % – 75 % or <50 % correctly typed, respectively. One laboratory did not analyze the inner and outer 
side of stain 10 separately, but as a mixed profile of two persons.  
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interpretation strategies leads also to differences in reporting of the re-
sults. This is exemplified by stain 9 (menstrual blood). Laboratories 6a 
and 7 correctly reported menstrual blood to be present. In addition, both 
participants detected the semen marker SEMG1. Laboratory 6a reported 
semen to be possibly present, while laboratory 7 did not report semen. 
The reason for this lays in different strategies to interpret the results. 
Laboratory 6 first used a screening multiplex, which contained primers 
for all body fluids, followed by body fluid specific multiplexes to confirm 
the results. A marker was called present, when 50 rfu were reached. A 
scoring tool was not used. In contrast, laboratory 7 used the scoring 
method (x = n/2) developed by Lindenbergh et al. [46], which is based 
on replicate analyses. The replicates are used to determine how often a 
signal is present (x = observed number of markers) relative to the times 
a signal could have occurred (n = maximum number of markers, which 
could have been detected per body fluid). Depending on the result of this 
ratio, a body fluid is reported as “observed” (x ≥ n/2), “not observed”(x 
= 0) or “sporadically observed, not reliable” (0 < x < n/2). Out of the 
maximal 12 possible peaks for semen, SEMG1 was detected in two 
replicates, scored as “sporadically observed, not reliable” and therefore 
not reported. We found that laboratories performing replicate analyses 
tended to show a higher number of additional markers compared to the 
remaining participants, because with each replicate chances of detecting 
additional markers are increased. The use of an interpretation tool such 
as the scoring method mentioned here is a good way to overcome this 
problem. Alternatives to the scoring methods are probabilistic models 
that apply quantitative information to predict the body fluids [48,49]. 
These methods consider the co-expression of all markers rather than just 
presence/absence of individual markers, and can assign a probability to 
each body fluid. 
For a reliable assessment of the body fluid specific mRNA markers 
there is not enough data in this study, but our results reflect somehow 
the intuitive rating of markers. E.g. blood and semen markers are very 
specific in the high input stains, and they do not appear regularly in non- 
target body fluids. The skin markers are very sensitive, but they also 
show up in other body fluids. Mucous membranes (like saliva, vaginal 
secretion and menstrual blood) have a very similar composition, 
therefore the respective mRNA markers tend to cross-react with other 
mucous membranes. 
DNA profiling of the 16 samples was straight forward. The high input 
stains (No. 1, 4, 8, 9, 10.1, 10.2, 12, 15) were typed easily, only in two 
stains a single dropout was observed. Even within the low input samples 
(No. 2, 3, 5, 6, 13, 16) full DNA profiles were obtained for most stains. 
Some laboratories reported mixed DNA profiles for the skin samples 
(stains 5 and 6), although they were collected from a single person. The 
donors were advised not to wash hands and arms before sample 
collection. Therefore, the additional detected alleles most likely origi-
nate from somebody touching the donor’s arms or from surfaces, which 
have been touched by the donor prior to sample collection. This stands 
in line with findings by Szkuta et al. [62] who reported that DNA which 
was transferred from one individual’s hand to another by handshake 
could be detected on different surfaces several hours post-handshake. A 
similar result was obtained by van den Berge et al. [63] who showed that 
background cellular material, which is unrelated to the case being 
analyzed, can be detected on any public or private item. In addition, 
Table 7 
Interpretation of the mRNA results by the laboratories. Samples are sorted into high input stains (No. 1, 4, 8, 9, 10.1, 10.2, 12, 15), low input stains (No. 2, 3, 5, 6, 13, 
16) and mixed stains (No. 7, 11, 14). Green shaded boxes represent correctly identified body fluids, light green coloring indicates the detection of additional body fluids 
besides the correct one, light red boxes represent stains, where markers are missing and therefore the body fluid was not correctly identified, red boxed depict no or 
incorrect results. In the mixed stain category yellow-green boxes identify samples where only one of the two body fluids in the stain was detected. +Laboratory 4 only 
used markers for saliva, menstrual blood and vaginal secretion ++Laboratory 7 did not use markers for skin +++Laboratory 1 and 6a reported possible RNA transfer 
between inside and outside during sampling. ++++Laboratory 1 reported to have swabbed both sides of the glass slide and thus indicated that results might be a 
contamination *Markers were detected under the read count threshold **Body fluid reported as possibly present in the stain. ***In routine casework, laboratory 4 does 
not report the detection of menstrual blood, even though markers for menstrual blood are present. Instead only vaginal secretion is reported to be present.  
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sample composition might vary between samples sent to participants in 
this study. Within the mixed stains, stain 11 (mixture of saliva and skin 
of mother and son) was the most difficult sample to interpret on the DNA 
level. The son having donated saliva was the major contributor of the 
DNA profile, while for the mother many alleles had dropped out. Mother 
and son share one allele per locus and therefore a minor contributor 
adding 0–1 alleles is even more challenging to detect. 
In summary, we found that mRNA profiling and RNA/DNA co- 
extraction strategies using different analysis methods can successfully 
be performed and applied to casework-like samples. Participating lab-
oratories were provided with a variety of different samples ranging from 
very high to very low input amounts. In general, high input stains were 
typed with high accuracy by all laboratories, regardless of the method 
used. Samples of low input or mixed stains were more challenging to 
analyze and interpret since a higher number of markers dropped out 
and/or additional unexpected markers not consistent with the cell type 
in question were detected, irrespective of the analysis strategy. Never-
theless, it could be shown that a plethora of different but valid analysis 
and interpretation strategies exist and are successfully applied in the 
Forensic Genetics community. This allows investigators to gain valuable 
information about the origin of crime scene samples and the course of 
events in a crime case. We would also like to highlight that the aim of 
this study was not to harmonize forensic RNA analysis across countries 
and laboratories, but to show that several different and valid in-
terpretations strategies are being applied, where each laboratory decides 
in its own way whether to report the presence of a body fluid based on 
the markers detected. Nonetheless, efforts aiming at optimizing and 
harmonizing interpretation approaches in order to achieve a higher 
consistency between laboratories might be desirable in the future. 
A continuative question is whether cell types and donors can be 
associated in a mixture. Two studies discourage from associating donor 
and cell type based on peak heights / read counts when performing 
combined RNA and DNA analyses [64,65]. Coding SNPs (cSNP) are 
found within body fluid specific mRNA transcripts and could directly 
link a body fluid to its donor [66]. A proof-of-concept study by Ingold 
et al. showed promising results when it came to linking a body fluid to its 
donor [65], although to increase discrimination power more SNPs are 
needed. A collaborative exercise was organized within the EURO-
FORGEN / EDNAP groups to test the performance of a 35-plex body fluid 
identification assay and a 35-plex cSNP assay. The results indicated that 
cSNPs can provide the investigator with valuable information about the 
donor / body fluid association [57]. 
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